The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Therapeutic equivalence of alendronate 70 mg onceweekly and alendronate 10 mg daily in the treatment of osteoporosis
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Black, D. M., Cummings, S. R., Karpf, D. B., Cauley, J. A., Thompson, D. E., Nevitt, M. C., Bauer, D. C., Genant, H. K., Haskell, W. L., Marcus, R., et al. (1996) · The Lancet · doi:10.1016/s0140-6736(96)07088-2 · Cited by 3,846
Self-citationMarshall, D., Johnell, O., & Wedel, H. (1996) · BMJ · doi:10.1136/bmj.312.7041.1254 · Cited by 3,709
Vertebral fracture assessment using a semiquantitative technique
Genant, H. K., Wu, C. Y., van Kuijk, C., & Nevitt, M. C. (1993) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650080915 · Cited by 3,691
Liberman, U. A., Weiss, S. R., Bröll, J., Minne, H. W., Quan, H., Bell, N. H., Rodriguez-Portales, J., Downs, R. W., Dequeker, J., Favus, M., et al. (1995) · New England Journal of Medicine · doi:10.1056/nejm199511303332201 · Cited by 2,288
Self-citationTrials to assess equivalence: the importance of rigorous methods: Fig 1
Jones, B., Jarvis, P., Lewis, J. A., & Ebbutt, A. F. (1996) · BMJ · doi:10.1136/bmj.313.7048.36 · Cited by 1,032
Intermittent Cyclical Etidronate Treatment of Postmenopausal Osteoporosis
Watts, N. B., Harris, S. T., Genant, H. K., Wasnich, R. D., Miller, P. D., Jackson, R. D., Licata, A. A., Ross, P., Woodson, G. C., Yanover, M. J., et al. (1990) · New England Journal of Medicine · doi:10.1056/nejm199007123230201 · Cited by 949
Storm, T., Thamsborg, G., Steiniche, T., Genant, H. K., & Sorensen, O. H. (1990) · New England Journal of Medicine · doi:10.1056/nejm199005033221803 · Cited by 935
Esophagitis Associated with the Use of Alendronate
de Groen, P. C., Lubbe, D. F., Hirsch, L. J., Daifotis, A., Stephenson, W., Freedholm, D., Pryor-Tillotson, S., Seleznick, M. J., Pinkas, H., & Wang, K. K. (1996) · New England Journal of Medicine · doi:10.1056/nejm199610033351403 · Cited by 764
Pols, H. A. P., Felsenberg, D., Hanley, D. A., Štepán, J., Muñoz-Torres, M., Wilkin, T. J., Qin-sheng, G., Galich, A. M., Vandormael, K., Yates, A. J., et al. (1999) · Osteoporosis International · doi:10.1007/pl00004171 · Cited by 593
Self-citationStatistical Principles for Clinical Trials
Kay, R. (1998) · Journal of International Medical Research · doi:10.1177/030006059802600201 · Cited by 573
Chavassieux, P. M., Arlot, M. E., Reda, C., Wei, L., Yates, A. J., & Meunier, P. J. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119668 · Cited by 523
Prevention of Bone Loss with Alendronate in Postmenopausal Women under 60 Years of Age
Hosking, D., Chilvers, C. E. D., Christiansen, C., Ravn, P., Wasnich, R., Ross, P., McClung, M., Balske, A., Thompson, D., Daley, M., et al. (1998) · New England Journal of Medicine · doi:10.1056/nejm199802193380801 · Cited by 488
Self-citationOverview of patient compliance with medication dosing: a literature review.
Greenberg, R. N. (1984) · PubMed · Cited by 419
Antifracture Efficacy of Antiresorptive Agents Are Related to Changes in Bone Density
Wasnich, R. D. (2000) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.1.231 · Cited by 417
Lewis, J. A. (1999) · Statistics in Medicine · doi:10.1002/(sici)1097-0258(19990815)18:15<1903::aid-sim188>3.0.co;2-f · Cited by 413
The bisphosphonate alendronate (MK-217) inhibits bone loss due to ovariectomy in rats
Seedor, J. G., Quartuccio, H. A., & Thompson, D. D. (1991) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650060405 · Cited by 407
Self-citationBalena, R., Toolan, B. C., Shea, M., Markatos, A., Myers, E. R., Lee, S. C., Opas, E. E., Seedor, J. G., Klein, H., & Frankenfield, D. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116872 · Cited by 396
Chesnut, C. H., McClung, M. R., Ensrud, K. E., Bell, N. H., Genant, H. K., Harris, S. T., Singer, F. R., Stock, J. L., Yood, R. A., Delmas, P. D., et al. (1995) · The American Journal of Medicine · doi:10.1016/s0002-9343(99)80134-x · Cited by 365
Self-citationPharmacokinetics of Alendronate
Porras, A. G., Holland, S. D., & Gertz, B. J. (1999) · Clinical Pharmacokinetics · doi:10.2165/00003088-199936050-00002 · Cited by 296
Elimination and Biochemical Responses to Intravenous Alendronate in Postmenopausal Osteoporosis
Khan, S. A., Kanis, J. A., Vasikaran, S., Kline, W. F., Matuszewski, B. K., McCloskey, E. V., Beneton, M. N. C., Gertz, B. J., Sciberras, D. G., Holland, S. D., et al. (1997) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1997.12.10.1700 · Cited by 293
Hochberg, M. C., Ross, P. D., Black, D., Cummings, S. R., Genant, H. K., Nevitt, M. C., Barrett-Connor, E., Musliner, T., Thompson, D., & for the Fracture Intervention Trial Research Group (1999) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199906)42:6<1246::aid-anr22>3.0.co;2-u · Cited by 287
Self-citationMcClung, M., Clemmesen, B., Daifotis, A., Gilchrist, N. L., Eisman, J., Weinstein, R. S., El Hajj Fuleihan, G., Reda, C., Yates, A. J., & Ravn, P. (1998) · Annals of Internal Medicine · doi:10.7326/0003-4819-128-4-199802150-00001 · Cited by 268
Self-citationBlack, D. M., Palermo, L., Nevitt, M. C., Genant, H. K., Epstein, R., Valentin, R. S., & Cummings, S. R. (1995) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650100610 · Cited by 253
Upper Gastrointestinal Tract Safety Profile of Alendronate: The Fracture Intervention Trial
Bauer, D. C. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.4.517 · Cited by 215
Prevention of Bone Loss With Alendronate in Postmenopausal Women Under 60 Years of Age
Hosking, D., Chilvers, C. E. D., Christiansen, C., Ravn, P., Wasnich, R., Ross, P., McClung, M., Balske, A., Thompson, D., Daley, M., et al. (1998) · Obstetrical & Gynecological Survey · doi:10.1097/00006254-199806000-00021 · Cited by 212
Self-citationDevogelaer, J. P., Broll, H., Correa-Rotter, R., Cumming, D. C., Nagant de Deuxchaisnes, C., Geusens, P., Hosking, D., Jaeger, P., Kaufman, J. M., Leite, M., et al. (1996) · Bone · doi:10.1016/8756-3282(95)00436-x · Cited by 191
Self-citationIntermittent Cyclical Etidronate Treatment of Postmenopausal Osteoporosis
WATTS, N. B., HARRIS, S. T., GENANT, H. K., WASNICH, E. D., MILLER, P. D., JACKSON, R. D., LICATA, A. A., ROSS, P., WOODSON, G. G., YANOVER, M. J., et al. (1991) · Obstetrical & Gynecological Survey · doi:10.1097/00006254-199101000-00023 · Cited by 190
Pamidronate: An unrecognized problem in gastrointestinal tolerability
Lufkin, E. G., Argueta, R., Whitaker, M. D., Cameron, A. L., Wong, V. H., Egan, K. S., O'Fallon, W. M., & Riggs, B. L. (1994) · Osteoporosis International · doi:10.1007/bf01622190 · Cited by 172
Clinical pharmacology of alendronate sodium
Gertz, B. J., Holland, S. D., Kline, W. F., Matuszewski, B. K., & Porras, A. G. (1993) · Osteoporosis International · doi:10.1007/bf01623002 · Cited by 159
Adámi, S., Passeri, M., Ortolani, S., Broggini, M., Carratelli, L., Caruso, I., Gandolini, G., Gnessi, L., Laurenzi, M. W., Lombardi, A., et al. (1995) · Bone · doi:10.1016/s8756-3282(95)00262-6 · Cited by 142
Risedronate in the Treatment of Paget's Disease of Bone: An Open Label, Multicenter Study
Siris, E. S., Chines, A. A., Altman, R. D., Brown, J. P., Johnston, C. C., Lang, R., McClung, M. R., Mallette, L. E., Miller, P. D., Ryan, W. G., et al. (1998) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1998.13.6.1032 · Cited by 141
Self-citationEsophageal Irritation due to Alendronate Sodium Tablets (Possible Mechanisms)
Peter, C. P., Handt, L. K., & Smith, S. M. (1998) · Digestive Diseases and Sciences · doi:10.1023/a:1018894827961 · Cited by 132
Compliance with Sulfonylureas in a Health Maintenance Organization: A Pharmacy Record–Based Study
Venturini, F., Nichol, M., Sung, J., Bailey, K., Cody, M., & Mccombs, J. (1999) · The Annals of Pharmacotherapy · doi:10.1345/aph.18198 · Cited by 115
Decreased bone turnover in oral contraceptive users
Garnero, P., Sornay‐Rendu, E., & Delmas, P. D. (1995) · Bone · doi:10.1016/8756-3282(95)00075-o · Cited by 115
Quality control of DXA instruments in multicenter trials
Faulkner, K. G., & McClung, M. R. (1995) · Osteoporosis International · doi:10.1007/bf01774010 · Cited by 105
Self-citationWeekly administration of alendronate: Rationale and plan for clinical assessment
Bone, H. G., Adámi, S., Rizzoli, R., Favus, M. J., Ross, P. D., Santora, A. C., Prahalada, S. R., Daifotis, A. G., Orloff, J. J., & Yates, J. (2000) · Clinical Therapeutics · doi:10.1016/s0149-2918(00)87974-6 · Cited by 97
Self-citationPreclinical pharmacology of alendronate
Rodan, G. A., Seedor, J. G., & Balena, R. (1993) · Osteoporosis International · doi:10.1007/bf01623001 · Cited by 67
Non-compliance in elderly people: evaluation of risk factors by longitudinal data analysis
Lau, H. S., Beuning, K. S., de Boer, A., Porsius, A. J., Postma-Lim, E., & Klein-Beemink, L. (1996) · Pharmacy World & Science · doi:10.1007/bf00579707 · Cited by 65
Appearance of a gastric ulcer during diphosphonate therapy in a woman with CRST syndrome.
Rl, S. (1977) · PubMed · Cited by 11
Appearance of a Gastric Ulcer During Diphosphonate Therapy in a Woman With CRST Syndrome
SAUNDERS, M. R. L. (1977) · Southern Medical Journal · doi:10.1097/00007611-197711000-00026 · Cited by 8
Cited by
Papaioannou, A., Morin, S., Cheung, A. M., Atkinson, S., Brown, J. P., Feldman, S., Hanley, D. A., Hodsman, A., Jamal, S. A., Kaiser, S. M., et al. (2010) · Canadian Medical Association Journal · doi:10.1503/cmaj.100771 · Cited by 1,749
Denosumab in postmenopausal women with low bone mineral density.
McClung, M. R., Lewiecki, E. M., Cohen, S. B., Bolognese, M. A., Woodson, G. C., Moffett, A. H., Peacock, M., Miller, P. D., Lederman, S. N., Chesnut, C. H., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa044459 · Cited by 1,228
Self-citationBekker, P. J., Holloway, D. L., Rasmussen, A. S., Murphy, R., Martin, S. W., Leese, P. T., Holmes, G. B., Dunstan, C. R., & DePaoli, A. M. (2004) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.040305 · Cited by 771
Treatment of postmenopausal osteoporosis
Delmas, P. D. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08827-x · Cited by 681
Hodgson, S. F., Watts, N. B., Bilezikian, J. P., Clarke, B. L., Gray, T. K., Harris, D. W., Conrad Johnston, C., Kleerekoper, M., Lindsay, R., Luckey, M. M., et al. (2003) · Endocrine Practice · doi:10.4158/ep.9.6.544 · Cited by 605
Self-citation
Metadata
- Authors
- Alendronate Once-Weekly Study Group, Schnitzer, T., Bone, H. G., Crepaldi, G., Adami, S., McClung, M., Kiel, D., Felsenberg, D., Recker, R. R., Tonino, R. P., Roux, C., Pinchera, A., Foldes, A. J., Greenspan, S. L., Levine, M. A., Emkey, R., Santora, A. C., Kaur, A., Thompson, D. E., Yates, J., & Orloff, J. J.
- Venue
- Aging Clinical and Experimental Research
- Published
- 2000-02
- Volume
- 12
- Issue
- 1
- Pages
- 1-12
- ISSN
- 1594-0667 (ISSN-L)
- 1720-8319
- OpenAlex
- W1966722256
- Cited by
- 394
- References
- 41
- FWCI
- 31.65
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.